ArticleBMC cancer2010

Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.

Fariborz Rashid-Kolvear et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.